ArticleBioengineering (Basel, Switzerland)2025
Feasibility of Smartphone-Based Markerless Motion Capture for Quantitative Gait Assessment in Pediatric Guillain-Barré Syndrome: A Two-Case Proof-of-Concept Study.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Validations and applications of markerless motion capture using OpenCap: a scoping review.Frontiers in digital health · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This two-case proof-of-concept study evaluated the feasibility and clinical utility of a smartphone-based markerless motion capture system for quantitative gait assessment in pediatric Guillain-Barré syndrome (GBS). Two children with GBS underwent overground gait analysis using a dual-smartphone setup (OpenCap), and three-dimensional hip, knee, and ankle kinematics were computed via OpenSim. Case 1, a boy with treatment-related fluctuation, demonstrated marked abnormalities in swing-phase limb advancement and ankle push-off that improved after six weeks of rehabilitation in parallel with gains in muscle strength, balance, and ambulation. Case 2, a girl recovering from acute inflammatory demyelinating polyneuropathy, exhibited residual reductions in hip and knee flexion and impaired ankle control despite normal strength, consistent with vestibular dysfunction. All assessments were completed within routine clinical time constraints and produced analyzable kinematic data using only two smartphones. These findings indicate that smartphone-based markerless motion capture is a feasible and informative method for detecting gait impairment and recovery patterns in pediatric GBS and may serve as an accessible digital biomarker to complement standard clinical evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.